Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.

Volume: 64, Issue: 2, Pages: 248 - 253
Published: Feb 1, 2017
Abstract
OBJECTIVES A simple and reliable biomarker for Crohn disease (CD) would be a valuable clinical tool. We hypothesized that anti-Saccharomyces cerevisiae antibody (ASCA) may be present in the stool of patients with CD. Accordingly, we measured ASCA in the stool and serum of children and adolescents with known or suspected inflammatory bowel disease (IBD). METHODS We included 114 patients 19 years or younger (73 boys) with IBD, including 83...
Paper Details
Title
Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.
Published Date
Feb 1, 2017
Volume
64
Issue
2
Pages
248 - 253
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.